Intramyocardial bone marrow mononuclear cells versus bone marrow-derived and adipose mesenchymal cells in a rat model of dilated cardiomyopathy

被引:14
|
作者
Dolores Carmona, M. [1 ,2 ,3 ]
Canadillas, Sagrario [1 ,2 ,3 ]
Romero, Miguel [1 ,3 ,4 ]
Blanco, Alfonso [5 ]
Nogueras, Sonia [1 ,2 ,3 ]
Herrera, Concha [1 ,2 ,3 ,6 ]
机构
[1] Maimonides Inst Biomed Res Cordoba IMIBIC, Cordoba, Spain
[2] Reina Sofia Univ Hosp, Cellular Therapy Unit, Ave Menendez Pidal S-N, Cordoba 14004, Spain
[3] Univ Cordoba, Cordoba, Spain
[4] Reina Sofia Univ Hosp, Cardiol Dept, Cordoba, Spain
[5] Univ Cordoba, Anat & Comparat Pathol Dept, Cordoba, Spain
[6] Reina Sofia Univ Hosp, Hematol Dept, Cordoba, Spain
关键词
animal model; dilated cardiomyopathy; growth factor; myocardial fibers organization; neovascularization; stem cell transplantation; STEM-CELLS; STROMAL CELLS; HEART-FAILURE; TRANSPLANTATION; TRIAL; INFUSION; THERAPY;
D O I
10.1016/j.jcyt.2017.05.006
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Background. Effects of cell therapy on dilated cardiomyopathy (DCM) have been investigated in pre-clinical models using distinct cellular types in each study. A single study that compares the effectiveness of different cells is lacking. Methods. We have compared the effects of intramyocardial injection (IMI) of bone marrow (BM)-derived mononuclear cells (MNCs), BM and adipose tissue (AT) mesenchymal stromal cells (BM-MSCs and AT-MSCs) on heart function, histological changes and myocardial ultrastructure in a rat model of DCM. Isogenic Wistar rats were used to isolate the different cell types and to induce DCM by autoimmune myocarditis. Animals were randomly assigned to receive BM-MNCs, BM-MSCs, AT-MSCs or placebo at day 42 by IMI. Serial echocardiography was used to assess cardiac function and hearts obtained after sacrifice at day 70, were used for histological and ultrastructural analysis. Serum levels of type B-natriuretic peptide (BNP) and vascular endothelial growth-factor (VEGF) were determined at different time points. Results. BM-MSC treatment induced significant improvement in ejection fraction (EF), fractional shortening (FS), left ventricular systolic diameter (LVESD) and systolic volume (LVESV). In contrast, changes in echocardiographic parameters with respect to pre-treatment values in animals receiving placebo, AT-MSCs or BM-MNCs were not statistically significant. EF and FS in animals receiving AT-MSCs were superior to those receiving placebo. BM-MSC transplantation induced also improvement in cardiac fibers organization and capillary density, fibrotic tissue reduction, increase in final VEGF concentration and BNP decrease. Discussion. IMI of BM or AT-MSCs improves LV function and induces more angiogenesis processes than BM-MNCs. In addition, BM-MSCs showed more anti-fibrotic effects and more ability to reorganize myocardial tissue compared with the other cell types.
引用
收藏
页码:947 / 961
页数:15
相关论文
共 50 条
  • [1] Intramyocardial and intracoronary autologous bone marrow-derived mesenchymal stromal cell treatment in chronic severe dilated cardiomyopathy
    Chin, Sze-Piaw
    Poey, Alfred C.
    Wong, Chee-Yin
    Chang, Sau-Kong
    Tan, Chiang-Soo
    Mei-Theng Ng
    Chew, Kee-Hock
    Lam, Kai-Huat
    Cheong, Soon-Keng
    CYTOTHERAPY, 2011, 13 (07) : 814 - 821
  • [2] Intramyocardial administration of autologous bone marrow mononuclear cells in a critically ill child with dilated cardiomyopathy
    Lacis, Aris
    Erglis, Andrejs
    CARDIOLOGY IN THE YOUNG, 2011, 21 (01) : 110 - 112
  • [3] Effect of bone marrow-derived mononuclear cells on nerve regeneration in the transection model of the rat sciatic nerve
    Goel, Rohit Kumar
    Suri, Vaishali
    Suri, Ashish
    Sarkar, Chitra
    Mohanty, Sujata
    Sharma, Meher Chand
    Yadav, Pradeep Kumar
    Srivastava, Arti
    JOURNAL OF CLINICAL NEUROSCIENCE, 2009, 16 (09) : 1211 - 1217
  • [4] Comparative analysis of canine mesenchymal stem cells and bone marrow-derived mononuclear cells
    Maeta, Noritaka
    Tamura, Katsutoshi
    Ezuka, Fuuna
    Takemitsu, Hiroshi
    VETERINARY WORLD, 2021, 14 (04) : 1028 - 1037
  • [5] Bone marrow-derived mesenchymal stem cells versus bone marrow nucleated cells in the treatment of chondral defects
    Zhang, Yi
    Wang, Fuyou
    Chen, Jiarong
    Ning, Zhigang
    Yang, Liu
    INTERNATIONAL ORTHOPAEDICS, 2012, 36 (05) : 1079 - 1086
  • [6] Differentiation into neurons of rat bone marrow-derived mesenchymal stem cells
    Guan, Ming
    Xu, Yaping
    Wang, Wei
    Lin, Shan
    EUROPEAN CYTOKINE NETWORK, 2014, 25 (03) : 58 - 63
  • [7] Acute homing of bone marrow-derived mononuclear cells in intramyocardial vs. intracoronary transplantation
    Makela, Jussi
    Anttila, Vesa
    Ylitalo, Kari
    Takalo, Reijo
    Lehtonen, Siri
    Makikallio, Timo
    Niemela, Eija
    Dahlbacka, Sebastian
    Tikkanen, Jonne
    Kiviluoma, Kai
    Juvonen, Tatu
    Lehenkari, Petri
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2009, 43 (06) : 366 - 373
  • [8] Effect of Bone Marrow-Derived Mesenchymal Stem Cells on Cochlear Function in an Experimental Rat Model
    Mittal, Rahul
    Ocak, Emre
    Zhu, Angela
    Perdomo, Mario M.
    Pena, Stefanie A.
    Mittal, Jeenu
    Bohorquez, Jorge
    Eshraghi, Adrien A.
    ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2020, 303 (03): : 487 - 493
  • [9] Valproic acid enhances the effect of bone marrow-derived mononuclear cells in a rat ischemic stroke model
    Suda, S.
    Katsura, K. I.
    Saito, M.
    Kamiya, N.
    Katayama, Y.
    BRAIN RESEARCH, 2014, 1565 : 74 - 81
  • [10] Umbilical Cord Versus Bone Marrow-Derived Mesenchymal Stromal Cells
    Huang, Yong-Can
    Parolini, Ornella
    La Rocca, Giampiero
    Deng, Li
    STEM CELLS AND DEVELOPMENT, 2012, 21 (15) : 2900 - 2903